Alligator Bioscience AB (FRA:7AL0) Other Income (Expense) : €0.24 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Other Income (Expense)?

Alligator Bioscience AB's other income expense for the Alligator Bioscience AB's pretax income for the three months ended in Mar. 2025 was €0.11 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was €0.24 Mil.

Alligator Bioscience AB Other Income (Expense) Historical Data

The historical data trend for Alligator Bioscience AB's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Other Income (Expense) Chart

Alligator Bioscience AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-0.04

0.11

-0.04

-0.05

-3.49

Alligator Bioscience AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															0.04	0.05	0.07	0.01	0.11

Alligator Bioscience AB Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.24 Mil.

Alligator Bioscience AB (FRA:7AL0) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Alligator Bioscience AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (FRA:7AL0) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 0RK9:UK 7AL0:Germany

Address

Medicon Village, Scheeletorget 1, Lund, SWE, 223 81

Website

https://www.alligatorbioscience.se

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.

Alligator Bioscience AB Headlines

No Headlines